Cost-Utility Analysis of Newer HER2- Testing Technologies to Target Trastuzumab in the Adjuvant Breast Cancer Setting
May 1, 2014, 00:00
10.1016/j.jval.2014.03.522
https://www.valueinhealthjournal.com/article/S1098-3015(14)00573-7/fulltext
Title :
Cost-Utility Analysis of Newer HER2- Testing Technologies to Target Trastuzumab in the Adjuvant Breast Cancer Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00573-7&doi=10.1016/j.jval.2014.03.522
First page :
A90
Section Title :
Cancer
Open access? :
No
Section Order :
1581